Evaluation of middle ear infections using light measurements

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on improving the diagnosis of middle ear infections, particularly in children, by utilizing LED-based multi-wavelength light absorption and scattering measurements. Researchers will send low-energy LED light into the ear canal to analyze the optical properties of the eardrum, determining the presence of fluid or inflammation. The results will be processed by a microprocessor to enhance diagnostic accuracy compared to traditional methods that rely on subjective visual assessments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Male/ female at all age- newborn to adult.
2. Non- pregnant woman.
3. Diagnose of middle ear infection and plan for surgery procedure.

Exclusion Criteria:

1. Pregnant woman
2. Incompetent adults (i.e. individuals with cognitive impairment)
3. No diagnose of middle ear infection and no plan for surgery procedure.
4. Adults with cognitive impairment and children of parents that are cognitively impaired and thus are unable to consent will be excluded from the study.

Where it's running

• Children's Hospital of Orange County (CHOC)
  Orange, California, United States Recruiting
• UCI Otolaryngology Clinic
  Orange, California, United States Recruiting

Study contacts

• Principal investigator: Elliot Botvinick — University of Calfornia Irvine
• Study coordinator: John Weidling, PhD
• Email: jweidlin@uci.edu
• Phone: 949-824-9613

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pilot test of an active surveillance approach for brain metastases during CNS-penetrant systemic therapy

  A small observational study tests whether an active surveillance plan for newly progressing brain metastases during CNS-penetrant systemic therapy is safe for patients.

  Recruiting University of California, Irvine · Orange, California · NCT07827001

• Nerve block to treat severe belly pain in the emergency department

  This study tests whether injecting anesthesia into the erector spinae plane can relieve non-surgical abdominal pain in the ED without relying on narcotics.

  Recruiting Early Phase 1 University of California, Irvine · Orange, California · NCT07826936

• Paclitaxel given inside the abdomen with systemic therapy for GI cancers with peritoneal spread

  This phase II study tests a combination of intraperitoneal and systemic chemotherapy (paclitaxel) in adults with digestive tract cancers that have spread to the peritoneum.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07795749

• Empowering patients to get lung cancer screening with support and navigation

  This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.

  Recruiting at 13 sites University of California, Irvine · Anaheim, California and 56 other locations · NCT07711691

• Metformin in PMP from appendiceal mucinous neoplasms

  This pilot study tests whether metformin is feasible to use in adults with pseudomyxoma peritonei caused by appendiceal mucinous tumors who have recurrent or unresected disease.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT07693452

• Methionine-Reduced Diet in Solid Tumors (early-phase)

  A small pilot study will test whether a methionine-reduced diet can change blood levels in adults with various solid tumors who are receiving standard cancer therapy.

  Recruiting Early Phase 1 University of California, Irvine · Orange, California · NCT07628634

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.